News Breaks |
|
|
| January 17, 2013 |
| 07:47 EDT |  | DSCO | Discovery Labs receives new U.S. patent for pulmonary surfactant formulations
Discovery Laboratories announced it has received a patent issued by the United States Patent and Trademark Office entitled "Pulmonary Surfactant Formulations." The claims of the patent provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028. |
|
|
News For DSCO From The Last 14 Days Check below for free stories on DSCO the last two weeks. |
|
|
| June 10, 2013 |
| 07:46 EDT | | DSCO | Discovery Labs responds to FDA request for clarification of submitted Surfaxin
Discovery Laboratories announced that it submitted a response to the FDA recent correspondence relating to Discovery Labs' recently updated product specifications for SURFAXIN. Discovery Labs expects that the FDA may take up to four months to review the information provided. If its plan is successful and the FDA agrees with the response, Discovery Labs expects to proceed with the commercial introduction of SURFAXIN in the fourth quarter of 2013. |
|
|
|
|
|
